PMID- 7597298 OWN - NLM STAT- MEDLINE DCOM- 19950803 LR - 20190904 IS - 0080-0015 (Print) IS - 0080-0015 (Linking) VI - 139 DP - 1995 TI - Human leukocyte antigens and multiple basal cell carcinomas. PG - 297-302 AB - This study presents data on human leukocyte antigen (HLA) phenotypes of 49 unrelated patients with multiple basal cell carcinomas (five or more BCC). Previous investigators noted an association with HLA-DR1 and a negative association with HLA-DR4. However, the previously found association was weak. HLA typing for class I (HLA-A, -B, -C) and class II antigens (HLA-DR, -DQ) was done from acid citrate dextrose (ACD)-stabilized peripheral blood using the modified lymphocytotoxicity test after T/B cell separation by immunobeads. Antigen frequencies of the patient group were compared to those of healthy individuals of a local German population (n = 716). Chi-square test and Fisher's exact test were used for statistical evaluation. While a significant association with HLA-DR1 was not observed in our study, we were able to confirm a significant decrease of HLA-DR4 in the patient group (12.2% versus 25.1%; p < 0.05; relative risk, RR, 0.48). In addition, HLA-Cw7 was significantly increased in the patient group (61.2% versus 40.8%; p < 0.01; RR, 2.29). In a subgroup of patients with multiple BCC located on the trunk (n = 25), the negative association with HLA-DR4 was even stronger (4% versus 25.1%; p < 0.02; RR, 0.12), whereas HLA-Cw7 was not significant (60.0% versus 40.8%; p = 0.06). Our results showed decreased frequencies of HLA-DR4 and increased frequencies of HLA-Cw7 in cases of multiple BCC, although statistical evaluation revealed only a weak association. This might be due to possible heterogeneity in this disease, e.g., BCC of the trunk versus BCC of the face, or any other cofactors.(ABSTRACT TRUNCATED AT 250 WORDS) FAU - Rompel, R AU - Rompel R AD - Department of Dermatology, Municipal Clinics of Kassel, Germany. FAU - Petres, J AU - Petres J FAU - Kaupert, K AU - Kaupert K FAU - Muller-Eckhardt, G AU - Muller-Eckhardt G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Recent Results Cancer Res JT - Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer JID - 0044671 RN - 0 (Antigens, Neoplasm) RN - 0 (HLA Antigens) SB - IM MH - Antigens, Neoplasm/analysis/genetics MH - Carcinoma, Basal Cell/genetics/*immunology MH - Disease Susceptibility/immunology MH - Facial Neoplasms/genetics/immunology MH - Gene Frequency MH - Genetic Predisposition to Disease MH - HLA Antigens/*analysis/genetics MH - Histocompatibility Testing MH - Humans MH - Immunophenotyping MH - Neoplasms, Multiple Primary/genetics/*immunology MH - Skin Neoplasms/genetics/*immunology EDAT- 1995/01/01 00:00 MHDA- 1995/01/01 00:01 CRDT- 1995/01/01 00:00 PHST- 1995/01/01 00:00 [pubmed] PHST- 1995/01/01 00:01 [medline] PHST- 1995/01/01 00:00 [entrez] AID - 10.1007/978-3-642-78771-3_22 [doi] PST - ppublish SO - Recent Results Cancer Res. 1995;139:297-302. doi: 10.1007/978-3-642-78771-3_22.